{"component": "definition", "props": {"groups": [{"size": 218, "samples": [{"hash": "4kdmCgnEV4b", "uri": "/contracts/4kdmCgnEV4b#adverse-event", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 32.0965080261, "published": true}, {"hash": "fznsThnAVdv", "uri": "/contracts/fznsThnAVdv#adverse-event", "label": "Collaborative Development & License Agreement", "score": 31.3390369415, "published": true}, {"hash": "23GorjdgR8Q", "uri": "/contracts/23GorjdgR8Q#adverse-event", "label": "Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)", "score": 27.1054077148, "published": true}], "snippet_links": [{"key": "clinical-trial-subject", "type": "clause", "offset": [49, 71]}, {"key": "related-to", "type": "definition", "offset": [145, 155]}, {"key": "the-product", "type": "definition", "offset": [156, 167]}, {"key": "without-limitation", "type": "clause", "offset": [179, 197]}, {"key": "associated-with", "type": "definition", "offset": [301, 316]}], "snippet": "means any untoward medical occurrence in a human clinical trial subject or in a patient who is administered a Product, whether or not considered related to the Product including, without limitation, any undesirable sign (including abnormal laboratory findings of clinical concern), symptom or disease associated with the use of such Product.", "hash": "93227931d0a6c369ce06d4c5066f3d0d", "id": 1}, {"size": 76, "samples": [{"hash": "4x1RfIAbBpt", "uri": "/contracts/4x1RfIAbBpt#adverse-event", "label": "Clinical Investigation Research Agreement", "score": 36.4757080078, "published": true}, {"hash": "1i5JUmaXqFb", "uri": "/contracts/1i5JUmaXqFb#adverse-event", "label": "Clinical Investigation Research Agreement", "score": 34.7751998901, "published": true}, {"hash": "5xPfGFmrcw3", "uri": "/contracts/5xPfGFmrcw3#adverse-event", "label": "Clinical Investigation Research Agreement", "score": 33.7889823914, "published": true}], "snippet_links": [{"key": "access-to", "type": "definition", "offset": [43, 52]}, {"key": "clinical-trials", "type": "definition", "offset": [84, 99]}], "snippet": "has the meaning given in the TGA document \u201cAccess to Unapproved Therapeutic Goods \u2013 Clinical Trials in Australia\u201d (October 2004) or replacement.", "hash": "39a80310100a27b996ad7cfa089587bf", "id": 2}, {"size": 60, "samples": [{"hash": "aNyA2lEIEiw", "uri": "https://www.tuev-nord.de/fileadmin/Content/TUEV_NORD_DE/zertifizierung/TUV_NORD_MDR_BUCH_EN.pdf", "label": "www.tuev-nord.de", "score": 19.0479793549, "published": false}, {"hash": "7TwkNkesdJK", "uri": "https://www.tuv-nord.com/fileadmin/user_upload/TUEV_NORD_MDR_including_M3.pdf", "label": "www.tuv-nord.com", "score": 18.8633995056, "published": false}, {"hash": "gIanjEF2Lfa", "uri": "https://www.parlament.gv.at/dokument/XXV/EU/135463/imfname_10701541.pdf", "label": "www.parlament.gv.at", "score": 12.0650892258, "published": false}], "snippet_links": [{"key": "clinical-signs", "type": "definition", "offset": [84, 98]}, {"key": "other-persons", "type": "clause", "offset": [164, 177]}, {"key": "the-context", "type": "clause", "offset": [182, 193]}, {"key": "related-to", "type": "definition", "offset": [238, 248]}], "snippet": "means any untoward medical occurrence, unintended disease or injury or any untoward clinical signs, including an abnormal laboratory finding, in subjects, users or other persons, in the context of a clinical investigation, whether or not related to the investigational device;", "hash": "7098c8db96a3d7bfad02d931a0230945", "id": 3}, {"size": 58, "samples": [{"hash": "8b5ASUCFZ29", "uri": "/contracts/8b5ASUCFZ29#adverse-event", "label": "Material Transfer Agreement (BioAge Labs, Inc.)", "score": 35.4120483398, "published": true}, {"hash": "6fj5KEemdWA", "uri": "/contracts/6fj5KEemdWA#adverse-event", "label": "Consulting Agreement (Spero Therapeutics, Inc.)", "score": 34.6043815613, "published": true}, {"hash": "jE1uXJjFZ8N", "uri": "/contracts/jE1uXJjFZ8N#adverse-event", "label": "Consulting Agreement (Spero Therapeutics, Inc.)", "score": 34.2334022522, "published": true}], "snippet_links": [{"key": "clinical-investigation-subject", "type": "definition", "offset": [54, 84]}, {"key": "pharmaceutical-product", "type": "definition", "offset": [100, 122]}, {"key": "causal-relationship", "type": "definition", "offset": [169, 188]}], "snippet": "means any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.", "hash": "710141390d69ee0c3d461f6c1256e32d", "id": 4}, {"size": 45, "samples": [{"hash": "aRjt03GLmAD", "uri": "https://www.parlament.gv.at/dokument/XXV/EU/133907/imfname_10697784.pdf", "label": "www.parlament.gv.at", "score": 12.0396766663, "published": false}, {"hash": "5TpDwDHqgC5", "uri": "https://tecurat.de/wp-content/uploads/2018/09/20180824_IVDR-EN_ME-bookmarks.pdf", "label": "tecurat.de", "score": 10.8165636063, "published": false}, {"hash": "22f2rtoQwok", "uri": "https://www.legislation.gov.uk/uksi/2019/791/made/data.pdf", "label": "www.legislation.gov.uk", "score": 10.7946615219, "published": false}], "snippet_links": [{"key": "management-decision", "type": "clause", "offset": [61, 80]}, {"key": "clinical-signs", "type": "definition", "offset": [127, 141]}, {"key": "other-persons", "type": "clause", "offset": [207, 220]}, {"key": "the-context", "type": "clause", "offset": [225, 236]}, {"key": "related-to", "type": "definition", "offset": [276, 286]}, {"key": "the-device", "type": "clause", "offset": [287, 297]}, {"key": "for-performance", "type": "clause", "offset": [298, 313]}], "snippet": "means any untoward medical occurrence, inappropriate patient management decision, unintended disease or injury or any untoward clinical signs, including an abnormal laboratory finding, in subjects, users or other persons, in the context of a performance study, whether or not related to the device for performance study;", "hash": "3d69a4017a092d997a1d38aa90a2ab9e", "id": 5}, {"size": 42, "samples": [{"hash": "6lsq1xPYQ9m", "uri": "/contracts/6lsq1xPYQ9m#adverse-event", "label": "Collaboration and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "cFk0EucoGSV", "uri": "/contracts/cFk0EucoGSV#adverse-event", "label": "Collaboration and License Agreement (Pozen Inc /Nc)", "score": 25.7227916718, "published": true}, {"hash": "3eTykk37SRc", "uri": "/contracts/3eTykk37SRc#adverse-event", "label": "Collaboration and License Agreement (Pozen Inc /Nc)", "score": 25.7227916718, "published": true}], "snippet_links": [{"key": "clinical-investigation-subject", "type": "definition", "offset": [53, 83]}, {"key": "pharmaceutical-product", "type": "definition", "offset": [107, 129]}, {"key": "as-designated", "type": "definition", "offset": [131, 144]}, {"key": "other-applicable-law", "type": "definition", "offset": [175, 195]}, {"key": "in-the-territory", "type": "clause", "offset": [196, 212]}], "snippet": "means any adverse medical occurrence in a patient or clinical investigation subject that is administered a pharmaceutical product, as designated under 21 CFR \u00a7 312.32 and any other Applicable Law in the Territory.", "hash": "05a3bf9be8e454641afbc8f1e128b751", "id": 6}, {"size": 40, "samples": [{"hash": "kdfUt8L3aWT", "uri": "/contracts/kdfUt8L3aWT#adverse-event", "label": "Cooperative Research and Development Agreement", "score": 31.6812076569, "published": true}, {"hash": "8YP4jSO9hYH", "uri": "/contracts/8YP4jSO9hYH#adverse-event", "label": "Cooperative Research and Development Agreement (Bavarian Nordic a/S / ADR)", "score": 27.0068454742, "published": true}, {"hash": "7pCjhmYaI6z", "uri": "/contracts/7pCjhmYaI6z#adverse-event", "label": "Cooperative Research and Development Agreement (Bavarian Nordic a/S / ADR)", "score": 27.0068454742, "published": true}], "snippet_links": [{"key": "human-subject", "type": "definition", "offset": [51, 64]}, {"key": "test-article", "type": "definition", "offset": [78, 90]}, {"key": "causal-relationship", "type": "definition", "offset": [126, 145]}, {"key": "associated-with", "type": "definition", "offset": [299, 314]}, {"key": "use-of-the-test", "type": "clause", "offset": [319, 334]}, {"key": "related-to", "type": "definition", "offset": [365, 375]}, {"key": "clinical-practice-guideline", "type": "definition", "offset": [393, 420]}, {"key": "federal-register", "type": "clause", "offset": [525, 541]}], "snippet": "or \u201cAE\u201d means any untoward medical occurrence in a Human Subject administered Test Article. An AE does not necessarily have a causal relationship with the Test Article, that is, it can be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of the Test Article, whether or not it is related to it. See FDA Good Clinical Practice Guideline (International Conference on Harmonisation (ICH) E6: \u201cGood Clinical Practice: Consolidated Guidance, 62 Federal Register 25, 691 (1997)).", "hash": "47504fd1746c9247de5590083ea8a94c", "id": 7}, {"size": 37, "samples": [{"hash": "dgfNIV8XQiM", "uri": "https://www.astellas.com/en/system/files/865991b3a5/sweden_po_en_20241016.pdf", "label": "www.astellas.com", "score": 15.476565361, "published": false}, {"hash": "lqIu106XwOz", "uri": "https://www.astellas.com/en/system/files/d7819ff92a/uk_po_en.pdf", "label": "www.astellas.com", "score": 13.7268190384, "published": false}, {"hash": "aYAvegHuDfJ", "uri": "https://www.astellas.com/en/system/files/4e84b43643/denmark_po_en.pdf", "label": "www.astellas.com", "score": 12.7797470093, "published": false}], "snippet_links": [{"key": "clinical-trial-subject", "type": "clause", "offset": [54, 76]}, {"key": "medicinal-product", "type": "clause", "offset": [92, 109]}, {"key": "causal-relationship", "type": "definition", "offset": [156, 175]}, {"key": "associated-with", "type": "definition", "offset": [338, 353]}, {"key": "related-to", "type": "definition", "offset": [412, 422]}], "snippet": "means any untoward medical occurrence in a patient or clinical trial subject administered a medicinal product and which does not necessarily have to have a causal relationship with this treatment. An Adverse Event can therefore be any unfavorable and unintended sign (e.g., an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product.", "hash": "4cebe9f69a959a8e730f47b86e46cf6d", "id": 8}, {"size": 34, "samples": [{"hash": "iLgRIARmFnW", "uri": "/contracts/iLgRIARmFnW#adverse-event", "label": "Nonstatutory Stock Option Agreement (Strategy Inc)", "score": 36.8384666443, "published": true}, {"hash": "4fqSjYnC9L9", "uri": "/contracts/4fqSjYnC9L9#adverse-event", "label": "Restricted Stock Unit Agreement (Strategy Inc)", "score": 36.8384666443, "published": true}, {"hash": "gVnmmQ9bHMP", "uri": "/contracts/gVnmmQ9bHMP#adverse-event", "label": "Restricted Stock Unit Agreement (MICROSTRATEGY Inc)", "score": 35.5954818726, "published": true}], "snippet_links": [{"key": "material-diminution", "type": "definition", "offset": [32, 51]}, {"key": "the-participant", "type": "clause", "offset": [55, 70]}, {"key": "base-compensation", "type": "clause", "offset": [111, 128]}, {"key": "the-requirement", "type": "clause", "offset": [137, 152]}, {"key": "by-the-company", "type": "clause", "offset": [153, 167]}, {"key": "principal-work-location", "type": "clause", "offset": [271, 294]}, {"key": "prior-to-the", "type": "clause", "offset": [307, 319]}, {"key": "change-in-control-event", "type": "clause", "offset": [320, 343]}], "snippet": "means the occurrence of (x) any material diminution in the Participant\u2019s authority, duties, responsibility, or base compensation, or (y) the requirement by the Company that the Participant principally works at a location that is more than 50 miles from the Participant\u2019s principal work location immediately prior to the Change in Control Event.", "hash": "9a93eacee52f88ad638ac54ef2a4457f", "id": 9}, {"size": 28, "samples": [{"hash": "erhcYaQphhW", "uri": "/contracts/erhcYaQphhW#adverse-event", "label": "Credit Agreement (Otter Tail Corp)", "score": 21.0, "published": true}, {"hash": "46ftgM2oDnv", "uri": "/contracts/46ftgM2oDnv#adverse-event", "label": "Credit Agreement (Otter Tail Corp)", "score": 21.0, "published": true}, {"hash": "15srD9y7mWB", "uri": "/contracts/15srD9y7mWB#adverse-event", "label": "Credit Agreement (Otter Tail Corp)", "score": 21.0, "published": true}], "snippet_links": [{"key": "material-adverse-effect-on-the-business", "type": "definition", "offset": [52, 91]}, {"key": "the-subsidiaries", "type": "clause", "offset": [180, 196]}, {"key": "the-guarantor", "type": "clause", "offset": [263, 276]}, {"key": "obligations-under-the-loan-documents", "type": "clause", "offset": [292, 328]}], "snippet": "means the occurrence of any event that could have a material adverse effect on the business, operations, property, assets or condition (financial or otherwise) of the Borrower and the Subsidiaries as a consolidated enterprise or on the ability of the Borrower or the Guarantor to perform its obligations under the Loan Documents.", "hash": "0d116b1c5fc657bd205a63064e4ef570", "id": 10}], "next_curs": "CloSVGoVc35sYXdpbnNpZGVyY29udHJhY3RzcjYLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIWYWR2ZXJzZS1ldmVudCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Adverse Event", "size": 2296, "snippet": "means any untoward medical occurrence in a human clinical trial subject or in a patient who is administered a Product, whether or not considered related to the Product including, without limitation, any undesirable sign (including abnormal laboratory findings of clinical concern), symptom or disease associated with the use of such Product.", "id": "adverse-event", "examples": ["If Takeda or any Affiliate has or receives any information regarding any <strong>Adverse Event</strong> which may be related to the use of any Product, then Takeda shall provide Petra with all such information in English within such reasonable timelines which enable \u2587\u2587\u2587\u2587\u2587 to comply with all Laws and relevant regulations and requirements."], "related": [["adverse-drug-reaction", "Adverse Drug Reaction", "Adverse Drug Reaction"], ["adverse-drug-experience", "Adverse Drug Experience", "Adverse Drug Experience"], ["serious-adverse-event", "Serious Adverse Event", "Serious <strong>Adverse Event</strong>"], ["material-adverse-event", "Material Adverse Event", "Material <strong>Adverse Event</strong>"], ["clinical", "Clinical", "Clinical"]], "related_snippets": [], "updated": "2026-06-24T04:23:54+00:00"}, "json": true, "cursor": ""}}